Clinical Trials
Braintumor Website

There are 20 trials:
Facility: Huntsman Cancer Institute
NCT Trial Name# of Centers

NCT02568267

  Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
129

NCT02667587

  An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
120

NCT02546102

  Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
64

NCT02526017

  Study of FPA008 in Combination With Nivolumab in Patients With Selected Advanced Cancers
39

NCT02709889

  Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
27

NCT02798406

  Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
11

NCT02844439

  Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
10

NCT02337491

  Pembrolizumab +/- Bevacizumab for Recurrent GBM
8

NCT03034135

  Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma
8

NCT02981940

  A Study of Abemaciclib in Recurrent Glioblastoma
7

NCT02008877

  Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
7

NCT02852655

  A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma
6

NCT02977780

  INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
5

NCT02390518

  Stereotactic Radiosurgery Dose Escalation for Brain Metastases
1

NCT02317783

  Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
1

NCT00707343

  [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
1

NCT00813566

  Multi-Tracer PET Assessment of Primary Brain Tumors
1

NCT01246869

  Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
1

NCT01580969

  Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma
1

NCT02272270

  Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED)
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites